HIV News and Research

RSS

Researchers suggest a theory for the evolution of HIV from SIV

A new study has shed light on how HIV may have evolved from the simian immunodeficiency virus (SIV) that originated in non-human primates.

5 Apr 2018

DNA-mimicking synthetic molecule could lead to new HIV treatment

Researchers have developed a synthetic compound that mimics the surface of DNA and is able to inhibit several DNA-processing enzymes.

4 Apr 2018

Atlanta struggles to meet MLK’s legacy on health care

While public safety commissioner Bull Connor's police dogs in 1963 attacked civil rights protesters in Birmingham, Ala., leaders in Martin Luther King Jr.'s hometown of Atlanta were burnishing its reputation as "the city too busy to hate."

4 Apr 2018

Atlas Award-winning study calls for more support to fight allergy epidemic in Africa

Allergies are on the rise in Africa, but with too few specialists to treat them, and a parallel increase in immune deficiency diseases, the situation is worse than we thought.

3 Apr 2018

'Molecular scissors' could play pivotal role in fighting diseases including HIV infection

One way to fight diseases including HIV infection and autoimmune disorders could involve changing how a naturally occurring enzyme called SAMHD1 works to influence the immune system, new research suggests.

3 Apr 2018

Study suggests HIV testing in emergency department as effective strategy to identify undiagnosed cases

South Africa has the worst epidemic of HIV in the world. According to the Joint United Nations Programme on HIV/AIDS, 19 percent of the global number of people living with HIV are in South Africa. Many people in South Africa and around the globe do not even know they have HIV.

3 Apr 2018

Grindr may be sharing user HIV status without consent

Gay dating app Grindr has released a new feature recently that allows its users to opt for HIV testing reminders. A new data analysis from SINTEF, a Norwegian research firm, has revealed that Grindr could be sharing this sensitive information regarding the users’ HIV status with two other companies.

2 Apr 2018

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.

2 Apr 2018

Staying alive: How to fight an opioid addiction

If you or a loved one wants to beat an opioid addiction, first make sure you have a handy supply of naloxone, a medication that can reverse an overdose and save your life.

2 Apr 2018

Monash scientists discover how gonorrhea-causing superbug evades the immune system

Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV infections. There has been a 63 percent rise in gonorrhea in Australia over the past five years.

30 Mar 2018

New $3.2 million grant funds research to advance promising malaria vaccine

The Global Health Innovative Technology Fund has awarded the University of Florida and partners in the United States and Japan $3.2 million to advance a promising vaccine to prevent transmission of malaria.

29 Mar 2018

Phase I clinical trial of HIV vaccines to begin in the U.S.

A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.

28 Mar 2018

New long-acting delivery system has potential to lessen side effects from NRTIs

An HIV diagnosis, while no longer constituting a death sentence, brings with it a lifetime, daily regimen of medication to help continually combat the virus.

27 Mar 2018

Without context or cushion, Do online medical results make sense?

As she herded her two young sons into bed one evening late last December, Laura Devitt flipped through her phone to check on the routine blood tests that had been performed as part of her annual physical. She logged onto the patient portal link on her electronic medical record, scanned the results and felt her stomach clench with fear.

27 Mar 2018

Measurement of tumor's metabolic activity could help determine prostate cancer prognosis

A new approach to analyzing prostate gland tissue may help address a major challenge in treating prostate cancer - determining which tumors are unlikely to progress and which could be life threatening and require treatment.

27 Mar 2018

Frequent and public opioid users may be best candidates for naloxone training

In response to America's opioid crisis, public health departments and community organizations across the country have started to train opioid users to reverse overdoses in other users with the opioid-blocker naloxone.

26 Mar 2018

Research misconduct allegations shadow likely CDC appointee

A more than 20-year-old controversy over shoddy HIV research is re-emerging as a significant criticism of President Donald Trump's likely pick to lead the Centers for Disease Control and Prevention.

21 Mar 2018

Congress tackles the opioid epidemic. But how much will it help?

The nation's opioid epidemic has been called today's version of the 1980s AIDS crisis. In a speech Monday, President Donald Trump pushed for a tougher federal response, emphasizing a tough-on-crime approach for drug dealers and more funding for treatment.

20 Mar 2018

ACTA trial in AIDS patients with cryptococcal meningitis validates new therapeutic regimens

The results of the ACTA trial were presented at the 9th IAS Conference on HIV Science held in Paris from 23 to 26 July 2017. Professor Thomas Harrison and his colleagues at St George's University of London, the Institut Pasteur in Paris, Paris Descartes University (Hôpital Necker-Enfants Malades), the ANRS site in Cameroon, and the MRC sites in Malawi, Tanzania, and Zambia show in this trial that new therapeutic regimens are of benefit in HIV-infected patients with cryptococcal meningitis.

15 Mar 2018

Use of HIV-prevention drug grows, but lags among non-whites

Eric Russell, 24, recently joined a health support group for young Latino and black gay men, where he learned about the HIV-prevention pill known as PrEP. He resisted the medication at first, convinced he didn't need it and fearful that taking it would stigmatize him.

15 Mar 2018

HIV News and Research

Researchers suggest a theory for the evolution of HIV from SIV

DNA-mimicking synthetic molecule could lead to new HIV treatment

Atlanta struggles to meet MLK’s legacy on health care

Atlas Award-winning study calls for more support to fight allergy epidemic in Africa

'Molecular scissors' could play pivotal role in fighting diseases including HIV infection

Study suggests HIV testing in emergency department as effective strategy to identify undiagnosed cases

Grindr may be sharing user HIV status without consent

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Staying alive: How to fight an opioid addiction

Monash scientists discover how gonorrhea-causing superbug evades the immune system

New $3.2 million grant funds research to advance promising malaria vaccine

Phase I clinical trial of HIV vaccines to begin in the U.S.

New long-acting delivery system has potential to lessen side effects from NRTIs

Without context or cushion, Do online medical results make sense?

Measurement of tumor's metabolic activity could help determine prostate cancer prognosis

Frequent and public opioid users may be best candidates for naloxone training

Research misconduct allegations shadow likely CDC appointee

Congress tackles the opioid epidemic. But how much will it help?

ACTA trial in AIDS patients with cryptococcal meningitis validates new therapeutic regimens

Use of HIV-prevention drug grows, but lags among non-whites

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News